Skip to content

Recent
Transactions

We represent foreign and domestic clients in a broad range of capital raising, M&A and other corporate transactions. Below are tombstone listings of certain of our recent representative transactions. Please click on a tombstone for a description of the specific deal.

All
  • All
  • Cryptocurrency
  • IPOs and Public Offerings
  • M&A
  • Other
  • PIPES and Private Placements
  • Private Fund
  • SPAC

BioPath Holdings Inc. $7,000,000

At-The-Market Offering (“ATM”)

July 2020

Press Release ›

Hudson Capital Inc.. $3,700,000

Registered Direct Offering

June 2020

Press Release ›

Genetic Technologies Limited $8,000,000

American Depository Shares

May 2020

Press Release ›

Relmada Therapeutics $75,000,000

At-The-Market Offering

May 2020

Press Release ›

Pareteum Corporation $3,750,000

Series C Redeemable Preferred Stock

March 2020

Press Release ›

Medigus Ltd. $5,000,000

ADSs and Warrants

May 2020

Press Release ›

Vuzix Corporation $11,250,000

Direct Offering of Common Stock

May 2020

Press Release ›

Lexaria Bioscience Corp. $2,000,000

Common Stock and Warrants

May 2020

Press Release ›

Safe-T Group Ltd. $8,400,000

ADSs and Warrants

Public Offering

Press Release ›

Beyond Air, Inc. $50,000,000

At-The-Market Offering

April 2020

Press Release ›

Genetic Technologies Limited $1,450,000

American Depository Shares

April 2020

Press Release ›

Genetic Technologies Limited $1,800,000

American Depository Shares

April 2020

Press Release ›

Cel-Sci Corporation $7,700,000

Common Stock Offering

March 2020

Press Release ›

Medalist Diversified REIT, Inc. $4,600,000

Series A Preferred Stock

February 2020

Press Release ›

Avinger, Inc. $4,500,000

Common Stock

February 2020

Press Release ›

ActiveGraf Inc. $900,000

Series A Preferred Stock

January 2020

Press Release ›

Biotricity Inc. $6,000,000

Preferred Series A Stock

December 2019

Press Release ›